Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.
  • Published Date:

    1999 Jan-Feb

  • Source:
    Emerg Infect Dis. 5(1):54-64.
Filetype[PDF-162.11 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 345.31 KB]
    Personal Author:
    Casadevall, A.
    Published Date:
    1996 Jul-Sep
    Source:
    Emerg Infect Dis. 2(3):200-208.
    Description:
    In the 19th century, it was discovered that immune sera were useful in treating infectious diseases. Serum therapy was largely abandoned in the 1940s because of the toxicity associated with the administration of heterologous sera and the introduction...
    File Type:
    Filetype[PDF - 345.31 KB]
  2. Filetype[PDF - 1.52 MB]
    Personal Author:
    Selvarajah, Suganya; Sexton, Nicole R.; Kahle, Kristen M.; Fong, Rachel H.; Mattia, Kimberly-Anne; Gardner, Joy; Lu, Kai; Liss, Nathan M.; Salvador, Beatriz; Tucker, David F.; Barnes, Trevor; Mabila, Manu; Zhou, Xiangdong; Rossini, Giada; Rucker, Joseph B.; Sanders, David Avram; Suhrbier, Andreas; Sambri, Vittorio; Michault, Alain; Muench, Marcus O.; Doranz, Benjamin J.; Simmons, Graham;
    Published Date:
    Sep 12 2013
    Source:
    PLoS Negl Trop Dis. 2013; 7(9).
    Description:
    The mosquito-borne alphavirus, chikungunya virus (CHIKV), has recently reemerged, producing the largest epidemic ever recorded for this virus, with up to 6.5 million cases of acute and chronic rheumatic disease. There are currently no licensed vaccin...
    File Type:
    Filetype[PDF - 1.52 MB]
  3. Filetype[PDF - 4.23 MB]
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.
    Published Date:
    January 2014
    Description:
    Sexually Transmitted Disease Surveillance 2012 presents statistics and trends for sexually transmitted diseases (STDs) in the United States through 2012. This annual publication is intended as a reference document for policy makers, program managers,...
    File Type:
    Filetype[PDF - 4.23 MB]
  4. Filetype[PDF - 4.81 MB]
    Personal Author:
    Braxton, Jim; Carey, Delicia; Davis, Darlene W.; Flagg, Elaine W.; Footman, Alison; Grier, LaZetta; Harvey, Alesia; Kidd, Sarah; Kirkcaldy, Robert D.; Llata, Eloisa; Nelson, Robert J.; Rivers, Fred; Stenger, Mark; Su, John; Torrone, Elizabeth; Weinstock, Hillard;
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.
    Published Date:
    December 2014
    Description:
    All Americans should have the opportunity to make choices that lead to health and wellness. An approach to improve health equity can address what the health providers can do with other partners working together. Interested committed public and privat...
    File Type:
    Filetype[PDF - 4.81 MB]
  5. Filetype[PDF - 3.79 MB]
    Personal Author:
    Wang, Susan A.
    Corporate Authors:
    National Center for HIV, STD, and TB Prevention (U.S.), Division of STD Prevention.
    Published Date:
    October 2003
    Description:
    "With 351,852 gonorrhea cases reported in 2002, gonorrhea is the second most frequently reported communicable disease in the United States. Gonorrhea rates in the United States declined 73.8% during 1975-1997. After a small increase in the rate in 19...
    File Type:
    Filetype[PDF - 3.79 MB]